Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Debt Ratio (2020 - 2024)

Syndax Pharmaceuticals (SNDX) has disclosed Debt Ratio for 5 consecutive years, with 0.47 as the latest value for Q4 2024.

  • For Q4 2024, Debt Ratio changed N/A year-over-year to 0.47; the TTM value through Dec 2024 reached 0.47, changed N/A, while the annual FY2024 figure was 0.47, N/A changed from the prior year.
  • Debt Ratio hit 0.47 in Q4 2024 for Syndax Pharmaceuticals, up from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.47 in Q4 2024 and bottomed at 0.04 in Q4 2021.
  • Average Debt Ratio over 4 years is 0.12, with a median of 0.08 recorded in 2021.
  • On a YoY basis, Debt Ratio climbed as much as 23.37% in 2021 and fell as far as 61.56% in 2021.
  • Syndax Pharmaceuticals' Debt Ratio stood at 0.07 in 2020, then tumbled by 33.27% to 0.04 in 2021, then increased by 11.32% to 0.05 in 2022, then soared by 853.76% to 0.47 in 2024.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.47, 0.05, and 0.05 for Q4 2024, Q2 2022, and Q1 2022 respectively.